Trazodone administration during ECT associated with cardiac conduction abnormality.
D003866:Depressive Disorder / Q000188:drug therapy / Q000628:therapy; D004565:Electroconvulsive Therapy / Q000379:methods*; D005260:Female; D006327:Heart Block / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D014196:Trazodone / Q000009:adverse effects*
D010879:Piperazines; D014196:Trazodone